NYSE ARCA | ETF
The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies.
From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 8.68% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.69% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 5.02% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 4.89% |
| NVZMY | Novozymes AS | Basic Materials | Specialty Chemicals | 4.85% |
| NVDA | NVIDIA Corporation | Technology | Semiconductors | 4.80% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.62% |
| BIO | Bio-Rad Laboratories Inc | Healthcare | Medical Devices | 4.52% |
| CDNS | Cadence Design Systems Inc | Technology | Software - Application | 3.90% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.87% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 3.60% |
| DD | Dupont De Nemours Inc | Basic Materials | Specialty Chemicals | 3.43% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.04% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |
| GOOGL | Alphabet Inc Class A | Communication Services | Internet Content & Information | 2.96% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.96% |
| NGVT | Ingevity Corp | Basic Materials | Specialty Chemicals | 2.73% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 2.67% |
| DAR | Darling Ingredients Inc | Consumer Defensive | Packaged Foods | 2.50% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.25% |